The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 21, 2020
Filed:
Aug. 30, 2018
Applicant:
The Procter & Gamble Company, Cincinnati, OH (US);
Inventors:
Richard John Dansereau, Cincinnati, OH (US);
Brian Laster, Cincinnati, OH (US);
Erin Swigart, Morrow, OH (US);
Ashraf Traboulsi, West Chester, OH (US);
Assignee:
The Procter & Gamble Company, Cincinnati, OH (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/135 (2006.01); A61P 25/20 (2006.01); A61K 9/00 (2006.01); A61K 31/138 (2006.01); A61K 9/19 (2006.01); A61K 47/12 (2006.01); A61K 47/22 (2006.01); A61J 1/03 (2006.01); A61K 31/4425 (2006.01); A61K 9/20 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 9/006 (2013.01); A61J 1/03 (2013.01); A61K 9/0053 (2013.01); A61K 9/0056 (2013.01); A61K 9/19 (2013.01); A61K 9/2013 (2013.01); A61K 9/2018 (2013.01); A61K 9/2027 (2013.01); A61K 9/2054 (2013.01); A61K 31/135 (2013.01); A61K 31/138 (2013.01); A61K 31/4425 (2013.01); A61K 45/06 (2013.01); A61K 47/12 (2013.01); A61K 47/22 (2013.01);
Abstract
An oral dosage form to deliver diphenhydramine through the sublingual or buccal mucosa. The oral dosage form can contain diphenhydramine, or a pharmaceutically acceptable salt thereof, a permeability enhancer, and a buffering agent. The buffering agent can achieve a pH of about 7.0 to about 8.0. The diphenhydramine can completely dissolve within about 2 minutes.